BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Costigan C, O'Sullivan AM, O'Connell J, Sengupta S, Butler T, Molloy S, O'Hara FJ, Ryan B, Breslin N, O'Donnell S, O'Connor A, Smith S, McNamara D. Helicobacter pylori: High dose amoxicillin does not improve primary or secondary eradication rates in an Irish cohort. World J Clin Cases 2024; 12(16): 2773-2779 [PMID: 38899284 DOI: 10.12998/wjcc.v12.i16.2773]
URL: https://www.wjgnet.com/2307-8960/full/v12/i16/2773.htm
Number Citing Articles
1
Raffaele Palmirotta, Concetta Cafiero, Marica Colella. Role of high-dose amoxicillin dual therapy for <i>Helicobacter pylori</i> eradication in an Irish cohort: A prospective studyWorld Journal of Clinical Cases 2024; 12(35): 6859-6863 doi: 10.12998/wjcc.v12.i35.6859
2
Sinéad M. Smith, Olga P. Nyssen, Rebecca FitzGerald, Thomas J. Butler, Deirdre McNamara, Asghar Qasim, Conor Costigan, Anna Cano-Catalá, Pablo Parra, Leticia Moreira, Francis Megraud, Colm O’Morain, Javier P. Gisbert. First-Line Prescriptions and Effectiveness of Helicobacter pylori Eradication Treatment in Ireland over a 10-Year Period: Data from the European Registry on Helicobacter pylori Management (Hp-EuReg)Antibiotics 2025; 14(7): 680 doi: 10.3390/antibiotics14070680